Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia
about
Integrated functional and mass spectrometry-based flow cytometric phenotyping to describe the immune microenvironment in acute myeloid leukemia.Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation.Bryonolic Acid Blocks Cancer Cell Clonogenicity and Invasiveness through the Inhibition of Fatty Acid: Cholesteryl Ester Formation.
P2860
Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cholesterol esterification inh ...... t chronic myelogenous leukemia
@en
type
label
Cholesterol esterification inh ...... t chronic myelogenous leukemia
@en
prefLabel
Cholesterol esterification inh ...... t chronic myelogenous leukemia
@en
P2093
P2860
P50
P1433
P1476
Cholesterol esterification inh ...... t chronic myelogenous leukemia
@en
P2093
Elie Traer
Jeffrey W Tyner
Stephen T Oh
P2860
P304
P356
10.1371/JOURNAL.PONE.0179558
P407
P577
2017-07-18T00:00:00Z